Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Inks $10M Financing Agreement With Milost Global

NEW YORK (GenomeWeb) – Canadian diagnostic developer GeneNews said today that it has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.

Under the agreement, Milost will initially purchase up to $3 million in unsecured convertible notes from GeneNews. The notes will be convertible at a price equal to the five-day volume-weighted average price of common shares of GeneNews on the Toronto Stock Exchange on the day of the draw-down notice, plus a 200 percent premium.

The notes will also have a five-year term from date of issue and bear interest at 5 percent annually, with interest payable quarterly in cash.

The initial $3 million draw-down is expected to be completed in the next 20 business days, and forms part of an equity and debt subscription agreement between GeneNews and Milost for up to $10 million in total proceeds.

The agreement also includes an investment from Milost of up to an additional $3 million in unsecured convertible notes to be drawn down at GeneNews' option, and up to $4 million to be drawn down, also at the company's option, in maximum installments of $1 million.

GeneNews said it will use proceeds from the agreement for working capital and corporate growth purposes, including the continued execution of its growth strategy for its Virginia-based clinical reference lab business, Innovative Diagnostic Laboratory.

In March, GeneNews reached a settlement agreement with the liquidating trust for its former partner Health Diagnostics Laboratory, which had formed the IDL venture along with GeneNews and Cobalt Healthcare Consultants.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.